Skip to main content
. 2021 Nov 24;12:707777. doi: 10.3389/fphar.2021.707777

FIGURE 1.

FIGURE 1

Flow diagram of the study selection process. HF, heart failure; MRA, mineralocorticoid receptor antagonist; SLGT2, sodium-glucose cotransporter-2.